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ABSTRACT
With diabetes, skeletal muscle mitochondrial quality control (mitochondrial fusion, fission & macroautophagy) is impaired. Geranylgeraniol (GG) is shown to have a protective effect on preventing
mitochondrial damage and muscle health; however, the effect of GG on a diabetic model is not known.
PURPOSE: To determine the effect of GG on mitochondrial quality control and muscle cross-sectional area
(CSA) in diabetic rats. METHODS: Thirty-five Sprague-Dawley rats were divided into three diet groups:
control diet (CON), high-fat diet with 35 mg/kg body weight of streptozotocin (HFD), and HFD with 800
mg/kg body weight of GG (GG). Due to the limited sample, a total of 21 (CON: n = 7; HFD: n = 7; GG: n =
7) rats’ muscle samples were used for this report. The soleus muscles were harvested after 7-weeks of
feeding and were analyzed for OPA1, MFN2, DRP1, pDRP, PINK1, Parkin, LC3A, and LC3B protein
content using western blot analysis. Muscle CSA were assessed using Image J. RESULTS: A significant (p
< 0.05) condition effect was observed for MFN2, DRP, LC3A, and LC3B protein contents and muscle CSA.
For mitochondrial fusion, GG (0.21 ± 0.08) had lower MFN2 than CON (0.43 ± 0.04; p = 0.007) and HFD
(0.65 ± 0.08; p = 0.010). For mitochondrial fission, GG (0.26 ± 0.07) had lower DRP than HFD (0.59 ± 0.07; p
= 0.019). For macro-autophagy, GG (1.08 ± 0.28) had lower LC3A than CON (2.81 ± 0.55; p = 0.028) and
HFD (3.99 ± 0.57; p = 0.010); whereas GG (0.63 ± 0.21) had lower LC3B than HFD (1.93 ± 0.24; p = 0.012).
No significant differences were observed for OPA1, pDRP, PINK1, Parkin, and LC3B/A. For muscle size,
CON (10,092.88 ± 104.67µm2) had larger CSA than GG (7284.69 ± 70.91µm2, p = 0.001) and HFD (5615.59 ±
59.97µm2; p = 0.001), whereas GG (7284.69 ± 70.91µm2) had larger CSA than HFD (5615.59 ± 59.97µm2; p =
0.001). CONCLUSION: GG supplementation could prevent mitochondrial fragmentation (reduction in
DRP), thus, potentially resulting in a decreased demand for mitochondrial fusion (reduction in MFN2). In
addition, a greater rate of autophagosome degradation than formation (reduction in LC3A and LC3B) was
observed (indicative of an increase in macro-autophagy). Improvement in mitochondrial quality could
potentially contribute to attenuating the reduction of muscle size in diabetic rats with GG
supplementation.
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